Literature DB >> 5057882

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.

W V Brown, M L Baginsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5057882     DOI: 10.1016/s0006-291x(72)80149-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  92 in total

1.  The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; G Perisutti; D W Brady; P Gartside; C J Glueck
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

2.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

5.  Increased high density lipoproteins in diabetic children.

Authors:  U Ewald; S Gustafson; T Tuvemo; B Vessby
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

Review 6.  [Lipid-protein-interactions of human apolipoproteins-structural aspects and models of lipoproteins (author's transl)].

Authors:  G Middelhoff; J Augustin; G Klose; H Greten
Journal:  Klin Wochenschr       Date:  1977-02-15

7.  Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II.

Authors:  J Stocks; D J Galton
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

8.  Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.

Authors:  D G Macfarlane; C A Midwinter; P A Dieppe; C H Bolton; M Hartog
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

9.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Authors:  C S Wang; W J McConathy; H U Kloer; P Alaupovic
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 10.  Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk.

Authors:  Jila Kaberi Otarod; Ira J Goldberg
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.